Literature DB >> 17277105

IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells.

Song Guo Zheng1, Juhua Wang, Pu Wang, J Dixon Gray, David A Horwitz.   

Abstract

IL-2 and TGF-beta both have important roles in the induction and maintenance of immunologic tolerance, but whether these cytokines act separately or together to achieve this effect is poorly understood. Although others have reported that IL-2 can directly enhance forkhead box protein P3 (Foxp3) transcription factor expression by natural CD4(+)CD25(+) regulatory T cells, in this study, we report that the role of IL-2 on the generation of peripheral regulatory CD4(+) cells is indirect. Ab neutralization studies and experiments with IL-2-deficient mice have revealed that IL-2 is required for TGF-beta to induce naive CD4(+)CD25(-) cells to become CD25(+) and express Foxp3, and develop the characteristic properties of CD4(+)CD25(+) regulatory cells. This effect of IL-2 on the generation and expansion of these adaptive Foxp3(+) regulatory cells is nonredundant, but IL-4, IL-7, and IL-15, other common gamma-chain cytokines, could sustain Foxp3 expression. Because subjects with autoimmune diseases often have defects in the production of IL-2 and/or TGF-beta, the generation of autologous T regulatory cells ex vivo with these cytokines for transfer in vivo may have considerable therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277105     DOI: 10.4049/jimmunol.178.4.2018

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  260 in total

1.  Requirements of transcription factor Smad-dependent and -independent TGF-β signaling to control discrete T-cell functions.

Authors:  Ai-Di Gu; Yunqi Wang; Lin Lin; Song S Zhang; Yisong Y Wan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

Review 2.  Learning to live together: harnessing regulatory T cells to induce organ transplant tolerance.

Authors:  Andrew Y Chang; Nupur Bhattacharya
Journal:  Yale J Biol Med       Date:  2011-12

Review 3.  Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

Authors:  Qin Lan; Huimin Fan; Valerie Quesniaux; Bernhard Ryffel; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2011-11-22       Impact factor: 6.216

4.  Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.

Authors:  Shuai Tang; Miranda L Moore; Jason M Grayson; Purnima Dubey
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

5.  Polyclonal CD4+Foxp3+ Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome.

Authors:  Qin Lan; Xiaohui Zhou; Huimin Fan; Maogen Chen; Julie Wang; Bernhard Ryffel; David Brand; Rajalakshmy Ramalingam; Pawel R Kiela; David A Horwitz; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2012-07-06       Impact factor: 6.216

Review 6.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

7.  Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot.

Authors:  Xiaohui Zhou; Julie Wang; Wei Shi; David D Brand; Zhongmin Liu; Huimin Fan; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2010-04-29       Impact factor: 6.216

8.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

9.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

Authors:  Heather Kopf; Gonzalo M de la Rosa; O M Zack Howard; Xin Chen
Journal:  Int Immunopharmacol       Date:  2007-09-20       Impact factor: 4.932

Review 10.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.